1 Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108. 2 Shen L,Shan YS,Hu HM,et al.Management of gastric cancer in Asia:resource-stratified guidelines[J].Lancet Oncol,2013,14(12):535-547. 3 Patel YC.Somatostatin and its receptor family[J].Front Neuroendocrinol,1999,20(3):157-198. 4 Hofland LJ,Vandamme T,Albertelli M,et al.Hormone and receptor candidates for target and biotherapy of neuroendocrine tumors[J].Front Horm Res,2015,44:216-238. 5 Tejeda M,Gaal D,Hullan L,et al.Evaluation of the antitumor efficacy of the somatostatin structural derivative TT-232 on different tumor models[J].Anticancer Res,2006,26(5a):3477-3483. 6 Xie Y,Chen S,Wang CH,et al.SOM230 combined with celecoxib prolongs the survival in nude mice with HepG-2 xenografts[J].Cancer Biol Ther,2011,12(1):86-92. 7 Theodoropoulou M,Stalla GK.Somatostatin receptors:from signaling to clinical practice[J].Front Neuroendocrinol,2013,34(3):228-252. 8 邵国庆,张南征,江兴松.生长抑素对人胃癌裸鼠种植瘤生长的影响[J].徐州医学院学报,2014,34(6):360-363. 9 邵国庆,张南征.生长抑素对裸鼠人胃癌种植瘤内VEGF和bFGF表达的影响[J].世界华人消化杂志,2014,22(36):5659-5664. 10 Folkman J,Shing Y.Angiogenesis[J].J Biol Chem,1992,267(16):10931-10934. 11 Reinacher-Schick A,Pohl M,Schmiegel W.Drug insight:antiangiogenic therapies for gastrointestinal cancers-focus on monoclonal antibodies[J].Nat Clin Pract Gastroenterol Hepatol,2008,5(5):250-267. 12 Dimova I,Popivanov G,Djonov V.Angiogenesis in cancer-general pathways and their therapeutic implications[J].J buon,2014,19(1):15-21. 13 Zhao DQ,Chen J,Wu YF,et al.Correlation between vascular endothelial growth factor and somatostatin receptor with progression and prognosis in gastric cancer[J].Hepatogastroenterology,2014,61(132):1154-1158. 14 赵滨,杨静,孙勇伟,等.生长抑素对胃癌VEGFs和VEGF受体影响的实验研究[J].实用癌症杂志,2011,26(1):27-30. 15 赵滨,杨静,杨培民,等.生长抑素对胃癌组织中VEGF-C及其受体的影响[J].现代肿瘤医学,2013,21(9):2037-2040. |